학술논문

Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortality
Document Type
Academic Journal
Source
European Heart Journal. Jan 01, 2007 28(1):59-64
Subject
Language
English
ISSN
0195-668X
Abstract
AIMS: To analyse the characteristics of infective endocarditis (IE) in patients with diabetes mellitus (DM), and to evaluate the prognostic significance of DM according to insulin use. METHODS AND RESULTS: A total of 559 patients with definite IE including 75 patients (13%) with DM (insulin use n=22; oral antidiabetic n=53) were evaluated. Comparison of insulin-DM, oral-DM, and non-DM patients showed an older age (66 ± 13, 66 ± 10, 58 ± 17, respectively; P=0.004) in DM patients, and more frequent IE on prosthetic valves (32, 11, and 15%, respectively; P=0.068) in insulin-DM patients. Oral streptococci (0, 8, and 18%, respectively; P=0.016) were less frequently the causative organism than staphylococci (64, 26, and 29%, respectively; P=0.002) in insulin-DM patients. Vegetations, dehiscence, abscess, and regurgitation rates did not differ among the three groups, nor did cardiac surgery rates (32, 47, and 48%, respectively; P=0.334), but in-hospital mortality was higher in insulin-DM patients (50, 19, and 15%; P < 0.001). In multivariable analysis, independently of other determinants of death (age, IE location, Staphylococcus aureus, history of heart failure, immunosuppression, creatinine serum), insulin-DM was a predictor of death (OR, 4.69; 95% CI, 1.77–12.44), whereas oral-DM was not. CONCLUSION: IE prognosis in insulin-DM patients is poor due to the coexistence of host and pathogen factors. Insulin-DM patients with IE may require specific management.